Desktop Site
|
26 Apr 24 | 16:00
|
Close
Equity
SME
Eq Drv
Currency
Commodity
Corporates
Get Quote
*
Notices
|
S&P
BSE SENSEX
73,730.16
-609.28
-0.82 %
Corporate Announcement
Security Code
531739
Company
GENNEX LABORATORIES LTD.
Exchange Received Time
14/02/2024 17:13:11
Exchange Disseminated Time
14/02/2024 17:13:13
Time Taken
00:00:02
Board Meeting Outcome for Outcome Of The Board Meeting Of Gennex Laboratories Limited Held On 14.02.2024 - Scrip Code: 531739/GENNEX |
2/14/2024 5:13:13 PM
In just concluded Meeting of Board of Directors, the Board Approved and considered the following items: 1. Unaudited (Standalone and Consolidated) Financial Statements for the Quarter and Nine months ended December 31, 2023 (annexed herewith); 2. Limited review reports from the Statutory Auditor on Unaudited (Standalone and Consolidated) Financial Statements for the Quarter and Nine months ended December 31, 2023 (annexed here with); 3. Acceptance of Resignation of Mr. Tiruvarur Muralidharan Gopalakrishnan, Whole time Director of the Company; 4. Appointment of Dr. S.CH. DHARMA RAO, as Additional Director (Non-Executive - Non Independent Director) of the Company. We hereby submit that the Board Meeting had commenced at 04:00 PM and concluded at 05:00 PM. This intimation is also uploaded on the Company website: www.gennexlab.com We request you to take the above information on record and acknowledge the receipt of the same.
Attachment
<< Back
Recently Viewed